Cisplatin-induced renal salt wasting syndrome

Southern Medical Journal
Tamim HamdiAshok Patel

Abstract

Cisplatin was the first platinum compound to be introduced as a chemotherapeutic agent with antineoplastic activity against a wide variety of solid tumors. Renal impairment with a decline in glomerular filtration has been the classical nephrotoxicity of cisplatin. Renal salt wasting syndrome is yet another, though it is not common. Previous studies were identified by searching the Pubmed database using the following keywords: cisplatin, cisplatin nephrotoxicity, renal salt wasting, and salt loosing nephropathy. Renal salt wasting syndrome has been described in 17 case reports since 1984. It is a rare side effect of cisplatin that manifests with polyuria, hypovolemia, and hyponatremia, and, because of similarities in clinical settings and laboratory values, it is frequently misdiagnosed as a syndrome of inappropriate antidiuretic hormone. Other causes of polyuria and hyponatremia should be excluded. Treatment aims at restoring the lost water and salt. Substituting cisplatin with carboplatin depends on individual clinical settings. Prognosis is excellent, as recovery was the rule in all the reported cases.

References

Aug 1, 1978·The American Journal of Medicine·N E Madias, J T Harrington
Sep 1, 1976·The American Journal of Medicine·K Thurau, J W Boylan
Jan 1, 1989·Cancer Chemotherapy and Pharmacology·G Daugaard, U Abildgaard
Aug 1, 1988·Clinical Pharmacology and Therapeutics·G DaugaardP P Leyssac
Jan 1, 1985·Cancer Chemotherapy and Pharmacology·J Uozumi, C L Litterst
Jan 1, 1987·Pediatric Hematology and Oncology·G VassalJ Lemerle
Jan 1, 1988·Annals of Internal Medicine·F N HutchisonG A Kaysen
Jun 1, 1986·The American Journal of Physiology·E E GordonH E Morgan
Jul 1, 1985·Biochemical Pharmacology·P T Daley-Yates, D C McBrien
Dec 1, 1973·Cancer·C P HoltonB E Favara
Aug 26, 1972·British Medical Journal·D M ParkJ F Robinson
Jul 1, 1983·American Journal of Nephrology·J UribarriH J Carroll
Jan 1, 1984·Medical and Pediatric Oncology·J KurtzbergT R Kinney
Jan 1, 1984·Medical and Pediatric Oncology·P J LammersL J Ettinger
Sep 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D V SkarlosG Klouvas
Aug 1, 1993·Gynecologic Oncology·T L Cornelison, E Reed
Feb 12, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M K KuhlmannH Köhler
Apr 24, 2001·Journal of the American Society of Nephrology : JASN·Soo-Wan KimKi-Chul Choi
Aug 2, 2002·American Journal of Clinical Oncology·Lequn CaoDavid Sumoza
Sep 18, 2002·The Journal of Clinical Investigation·Ganesan Ramesh, W Brian Reeves
Dec 24, 2002·Cancer Chemotherapy and Pharmacology·Andreas EkbornHans Ehrsson
Dec 31, 2002·Journal of the American Society of Nephrology : JASN·Danyelle M TownsendMarie H Hanigan
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert F OzolsUNKNOWN Gynecologic Oncology Group
Sep 19, 2003·Seminars in Nephrology·Istvan Arany, Robert L Safirstein
Oct 31, 2003·Oncology·J Klastersky
Dec 12, 2003·Clinical Lung Cancer·Akila V IyerAnthony S Arcenas
Jan 14, 2004·Kidney International·Ganesan Ramesh, W Brian Reeves
May 20, 2004·American Journal of Physiology. Renal Physiology·Istvan AranyRobert L Safirstein
Oct 30, 2004·Acta Oto-laryngologica. Supplementum·Makoto KusukiHideo Yamane
Jul 18, 2006·The American Journal of Medicine·Gary L Robertson
Jun 7, 2007·Journal of the National Cancer Institute·Andrea ArdizzoniUNKNOWN CISCA (CISplatin versus CArboplatin) Meta-analysis Group

❮ Previous
Next ❯

Citations

Apr 10, 2013·Asian Pacific Journal of Tropical Biomedicine·P A ArunkumarM S Belliyappa
May 24, 2012·The Oncologist·Jorge J CastilloEric Justice
Feb 27, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Goce SpasovskiUNKNOWN Hyponatraemia Guideline Development Group
Feb 27, 2014·European Journal of Endocrinology·Goce SpasovskiUNKNOWN Hyponatraemia Guideline Development Group
Feb 18, 2016·Journal of Cancer Research and Therapeutics·Erman AtasGokhan Kalkan
Jan 10, 2016·Clinica Chimica Acta; International Journal of Clinical Chemistry·Liyun CaoQing H Meng
Dec 24, 2013·Advances in Chronic Kidney Disease·Mitchell H Rosner, Alan C Dalkin
Mar 26, 2014·European Journal of Cancer Care·G F Abu ZeinahA Allam
Mar 5, 2016·European Journal of Pharmacology·George LiamisMoses S Elisaf
Dec 22, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Bhavna Bhasin, Juan Carlos Q Velez
Aug 23, 2011·CA: a Cancer Journal for Clinicians·Mark A LewisTimothy J Moynihan
Sep 3, 2011·European Journal of Cancer Care·N FurukawaH Kobayashi
Dec 20, 2014·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·J S ChoiS W Kim
Apr 9, 2015·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yasuhiro ArakawaKatsunori Nishikawa
Dec 5, 2014·Pflügers Archiv : European journal of physiology·Friedrich C Luft
Sep 26, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hege S HaugnesSophie D Fosså
Jun 28, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Balraj Singh GillSanjeev Kumar
Aug 20, 2017·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Chris D BartonDaniel B Hawcutt
Mar 15, 2019·Clinical Endocrinology·Alice NervoEmidio Grossi
Nov 21, 2012·Nature Reviews. Nephrology·Robert W SchrierDmitry Shchekochikhin
Jun 25, 2019·Current Opinion in Nephrology and Hypertension·Abhijat Kitchlu, Mitchell H Rosner
Sep 16, 2017·Terapevticheskiĭ arkhiv·D Yu ShchekochikhinE M Shilov
Nov 10, 2015·Nihon Jibiinkoka Gakkai kaiho·Taro FujikawaTakeshi Beppu
Aug 6, 2020·Cancers·Antonio G SoaresTarek Mohamed Abd El-Aziz
Jun 3, 2017·Case Reports in Nephrology·Phuong-Chi PhamPhuong-Thu Pham
Sep 19, 2018·Esophagus : Official Journal of the Japan Esophageal Society·Ayako ShimadaYuko Kitagawa
Jun 9, 2020·Frontiers in Oncology·Ignazio VerziccoAderville Cabassi
Jun 5, 2020·Kidney International·Biruh T WorkenehHelbert Rondon-Berrios
Jun 30, 2021·Clinical and Translational Medicine·Devasier BennetFrederic Zenhausern

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Related Papers

The American Journal of the Medical Sciences
Xin YaoKenneth Nugent
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Lubomir BodnarCezary Szczylik
© 2021 Meta ULC. All rights reserved